Dr David Kerr reports on mounting evidence of the significant antitumor activity of yttrium-90 in hepatic metastatic CRC when Y90 microspheres are delivered via the hepatic artery.
Dr David Kerr reports on mounting evidence of the significant antitumor activity of yttrium-90 in hepatic metastatic CRC when Y90 microspheres are delivered via the hepatic artery.